Clicky

Equillium, Inc.(EQ) News

Date Title
Oct 7 Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
Sep 10 Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
Aug 28 Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
Jun 12 Equillium to be included in the Russell Microcap® Index
May 29 Equillium to Present at the Jefferies Global Healthcare Conference
May 14 Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
May 9 Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
May 9 Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
May 7 Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 2 We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate
Apr 3 Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 1 5 Stocks That More Than Doubled in Q1 With More Gains Ahead
Apr 1 Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Mar 25 Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates
Mar 25 Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
Mar 22 Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
Mar 22 Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20%
Mar 4 The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark
Jan 29 15 Cash-Rich Penny Stocks Hedge Funds Are Buying
Dec 21 Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease